Want to join the conversation?
$AET and $MRK entered into unique value-based contract that supports objectives to help adult patients with type 2 diabetes access appropriate treatment. $MRK's rebates on Januvia and Janumet will be based in part on products' contributions to help $AET's commercial member population with type 2 diabetes achieve or maintain treatment objectives.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th
Wow! $MCD scores again.